Krystal Biotech Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2019
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2019
Revenue	359.21	290.52	50.7	-	-	-	Upgrade
Revenue Growth (YoY)	116.08%	473.02%	-	-	-	-	Upgrade
Cost of Revenue	23.83	20.06	3.09	-	-	-	Upgrade
Gross Profit	335.38	270.45	47.61	-	-	-	Upgrade
Selling, General & Admin	127.88	113.69	98.4	78.84	41.99	15.06	Upgrade
Research & Development	55.7	53.57	46.43	42.46	27.88	17.94	Upgrade
Operating Expenses	183.58	167.26	144.83	121.3	69.88	33	Upgrade
Operating Income	151.8	103.2	-97.23	-121.3	-69.88	-33	Upgrade
Interest Expense	-	-	-	-	-1.49	-	Upgrade
Interest & Investment Income	29.46	29.66	22.62	5.22	0.2	0.83	Upgrade
EBT Excluding Unusual Items	181.25	132.86	-74.6	-116.08	-71.17	-32.17	Upgrade
Gain (Loss) on Sale of Assets	-	-	100	-	-	-	Upgrade
Legal Settlements	-12.5	-37.5	-12.5	-25	-	-	Upgrade
Pretax Income	168.75	95.36	12.9	-139.98	-69.57	-32.17	Upgrade
Income Tax Expense	22.03	6.2	1.97	-	-	-	Upgrade
Net Income	146.73	89.16	10.93	-139.98	-69.57	-32.17	Upgrade
Net Income to Common	146.73	89.16	10.93	-139.98	-69.57	-32.17	Upgrade
Net Income Growth	38.50%	715.58%	-	-	-	-	Upgrade
Shares Outstanding (Basic)	29	29	27	25	22	19	Upgrade
Shares Outstanding (Diluted)	30	30	28	25	22	19	Upgrade
Shares Change (YoY)	1.66%	7.16%	8.87%	14.85%	18.15%	18.15%	Upgrade
EPS (Basic)	5.09	3.12	0.40	-5.49	-3.13	-1.71	Upgrade
EPS (Diluted)	4.91	3.00	0.39	-5.49	-3.13	-1.71	Upgrade
EPS Growth	36.22%	669.23%	-	-	-	-	Upgrade
Free Cash Flow	185.44	119.18	-100.6	-153.55	-116.27	-40.93	Upgrade
Free Cash Flow Per Share	6.20	4.01	-3.63	-6.02	-5.24	-2.18	Upgrade
Gross Margin	93.37%	93.09%	93.90%	-	-	-	Upgrade
Operating Margin	42.26%	35.52%	-191.77%	-	-	-	Upgrade
Profit Margin	40.85%	30.69%	21.56%	-	-	-	Upgrade
Free Cash Flow Margin	51.63%	41.02%	-198.43%	-	-	-	Upgrade
EBITDA	153.16	105.66	-93.32	-118.65	-67.11	-31.15	Upgrade
EBITDA Margin	42.64%	36.37%	-184.07%	-	-	-	Upgrade
D&A For EBITDA	1.36	2.47	3.91	2.64	2.77	1.85	Upgrade
EBIT	151.8	103.2	-97.23	-121.3	-69.88	-33	Upgrade
EBIT Margin	42.26%	35.52%	-191.77%	-	-	-	Upgrade
Effective Tax Rate	13.05%	6.50%	15.24%	-	-	-	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.